Does a generic drug label have to match the brand label, wrong words and all?

Generic drug labeling generally has to be the same as the last approved labeling of the brand, the reference listed drug (RLD), apart from a set of permitted differences. That means a correctly spelled wrong word in the brand's text can be copied faithfully into a generic's. A careful match to the brand is not the same as a read for meaning.

This page is general information, not legal or regulatory advice.

What the same-as rule says

21 CFR 314.94(a)(8)(iv) says labeling proposed for a generic must be the same as the labeling approved for the reference listed drug, except for changes required because of an approved petition or because the two products are made or distributed by different manufacturers. The regulation says those differences may include expiration date, formulation, bioavailability or pharmacokinetics, labeling revisions to comply with current FDA labeling guidelines or guidance, and omitting an indication or other aspect of labeling protected by patent or exclusivity.

The FDA's generic drug labeling resources page gives examples of permissible differences: manufacturer, packer or distributor information, package size, inactive ingredients, information protected by patent or exclusivity, and differences due to an approved suitability petition.

21 CFR 314.127(a)(7) says the FDA may refuse to approve a generic application if the information submitted doesn't show that the proposed labeling is the same as the reference listed drug's, apart from those kinds of differences.

Keeping up with brand changes

The FDA says generic application holders are expected to promptly update their labeling after the FDA approves changes to the brand's labeling, and should routinely review the last approved brand labeling on Drugs@FDA to make sure their labeling meets the same-as requirements.

Why copying faithfully copies wrong words too

Our view: the same-as rule rewards an exact match, and an exact match carries over whatever the source says. If the brand text has a real word in the wrong spot, a perfect comparison passes it. For more on that gap, see compare-to-master vs read-for-meaning.

Made-up example: a brand update adds a warning that should read "hypotension" but prints "hypertension". A generic team that matches the update character for character copies the wrong word, and a side-by-side check against the brand shows no difference.

Why spellcheck misses it

Both words are real and spelled correctly, so spellcheck passes them. A comparison tool passes them too, because the generic matches the brand exactly.

What to check next

Practice advice:

• After each brand labeling update, read the changed lines for meaning, not only for a match.
• Start with the new or revised warnings, dosing and contraindications.
• If a brand line looks wrong, flag it to your own regulatory team rather than changing your copy on your own. Our reading: a generic is expected to match, so the fix is that team's call, not the reviewer's alone.
• Read the permitted differences you add yourself, such as your own manufacturer details, with the same care.

For the same copy problem on biologics, see biosimilar label wording errors.

This is our reading of public guidance, not legal or regulatory advice.

Sources

• eCFR: 21 CFR 314.94
• eCFR: 21 CFR 314.127
• FDA: Generic Drugs – Specific Labeling Resources

Last reviewed: October 18, 2026

More on contextual errors in FDA DailyMed labels.

Questions about wording on your own labels? Talk to us.

We scan freshly published FDA DailyMed labels every day and pull out these high-stakes wrong words.

Every Tuesday and Friday, a new case like this lands in your inbox if you subscribe.

Does a generic label have to match the brand label?

Generally yes. 21 CFR 314.94(a)(8)(iv) says generic labeling must be the same as the reference listed drug's labeling, apart from permitted differences such as manufacturer details and inactive ingredients.

If the brand label has a wrong word, does the generic copy it?

It can. Matching the brand is the rule, so a side-by-side check passes a wrong word that's in the brand text. Only a read for meaning catches it.

How do generic teams stay current with brand label changes?

The FDA says generic application holders should routinely review the brand's last approved labeling on Drugs@FDA and promptly update their own labeling.

What differences are allowed between a generic and a brand label?

The FDA lists examples such as manufacturer, packer or distributor information, package size, inactive ingredients, and information protected by patent or exclusivity.

What if a generic team spots a wrong word in the brand label?

Practice advice, not regulatory advice: flag it to your own regulatory team rather than changing your copy on your own. Our reading is that generic labeling is expected to match the brand.